May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Efficacy of Autologous Serum in Post-Laser Epithelial Keratectomy (LASEK) Patients
Author Affiliations & Notes
  • S.B. Yee
    Hermann Eye Center, The University of Texas Health Science Center at Houston, Houston, TX, United States
  • N. Lin
    Hermann Eye Center, The University of Texas Health Science Center at Houston, Houston, TX, United States
  • A.Z. Chuang
    Hermann Eye Center, The University of Texas Health Science Center at Houston, Houston, TX, United States
  • R.W. Yee
    Hermann Eye Center, The University of Texas Health Science Center at Houston, Houston, TX, United States
  • Footnotes
    Commercial Relationships  S.B. Yee, None; N. Lin, None; A.Z. Chuang, None; R.W. Yee, None.
  • Footnotes
    Support  NEI Grant EY10608
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2636. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.B. Yee, N. Lin, A.Z. Chuang, R.W. Yee; The Efficacy of Autologous Serum in Post-Laser Epithelial Keratectomy (LASEK) Patients . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2636.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the efficacy of 20% autologous serum for use as a therapeutic eye drop to reduce haze in laser epithelial keratectomy (LASEK) patients. Methods: This study involved retrospective case studies of LASEK patients at the Hermann Eye Center from 1999-2002. A solution of 20% autologous serum was used as eye drops intra-operatively and post-operatively in 11 patients (21 eyes) undergoing LASEKby a single surgeon (RWY). The autologous serum solution was prepared by obtaining 20 cc of the patient's blood, centrifuging the blood for 4000 rpm/min for 4 minutes, and diluting the serum with balanced salt solution (BSS) to achieve a final concentration of 20%. Eighty five eyes in 52 patients undergoing LASEK did not receive any autologous serum solution. LASEK was performed using a modified Camellin technique with a Alcon Autonomous LADARVision® 4000 Excimer Laser System. Corneal haze was assessed by a single observer (RWY) and was graded from 0 (none) to 4+ (severe with iris features obscured) during a 3-6 month period. Results: The age of patients in the treatment group ranged from 27 to 45 years of age (mean age was 38.2 years ± 5.1) and in the control group ranged from 24 to 67 years of age (mean age was 40.9 years ± 9.6). There were no statistical differences in age range between the treatment and the control groups (P=0.10). There were no statistical differences in mean ablation depth and in ablation depth/corneal thickness ratio (AD/CT) between the treatment and control groups (P=0.07 and 0.08, respectively). A high AD/CT ratio (AD/CT > 0.18) has been associated with an increased risk of haze. Nonetheless, patients who received 20% autologous serum had a lower incidence of post-operative corneal haze (regardless of whether the patient had high or low AD/CT group) during the 3-6 month follow up period.  

Keywords: cornea: clinical science • wound healing • clinical (human) or epidemiologic studies: out 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×